Latest Breaking News On - Heart failure questionnaire - Page 2 : comparemela.com

BioCardia Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure

BioCardia Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDavid mcclungPeter altmanMiranda petoCenters for medicareCardiamp cell therapy programDrug administrationMaryland stem cell research fundMedicaid servicesBiocardia incExchange commission onMajor adverse cardiovascularMinnesota livingHeart failure questionnaireChief executiveCell therapy

BioCardia (BCDA) Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure

BioCardia (BCDA) Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPeter altmanDrug administrationBiocardia incMajor adverse cardiovascularMinnesota livingHeart failure questionnaireChief executive

AskBio Presents Preliminary Data from Phase 1 Trial of Gene Therapy for Congestive Heart Failure (CHF) at the 2023 American Heart Association Scientific Sessions

/PRNewswire/ Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today.

United statesUnited kingdomCity ofResearch triangle parkNorth carolinaLitsag kraniasTimothyd henryCanwen jiangSteering committee memberGlobal public health burden of heart failureDrug administrationAmerican heart associationAmerican heart association scientific sessionsCenters for disease controlAsklepios biopharmaceutical incTrademark office

AskBio Presents Preliminary Data from Phase 1 Trial of Gene Therapy for Congestive Heart Failure (CHF) at the 2023 American Heart Association Scientific Sessions

AskBio Presents Preliminary Data from Phase 1 Trial of Gene Therapy for Congestive Heart Failure (CHF) at the 2023 American Heart Association Scientific Sessions
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

Research triangle parkNorth carolinaUnited statesUnited kingdomCity ofLitsag kraniasTimothyd henryCanwen jiangAsklepios biopharmaceutical incTrademark officeSteering committee memberAmerican heart associationBayer agGlobal public health burden of heart failureUniversity of cincinnatiDrug administration

BioCardia Reports Third Quarter 2023 Business Highlights

SUNNYVALE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the.

United statesMiranda petoPeter altmanDavid mcclungYork heart association classExchange commissionDevice agencyCompany annual report on formMaryland stem cell research fundBiocardia incCompany phaseExchange commission onMedicaid servicesChronic myocardial ischemiaAutologous cell therapyIschemic heart failure